Iranian researchers succeeded in producing PolyPill tablets to prevent myocardial infarction and strokes, and provided the strongest scientific evidence of the effect of this combination drug on significant reduction of cardiovascular diseases and myocardial infarction and strokes in the largest clinical trial of this kind in the world.
The meeting of 100 international scientists, including some researchers from Iran, seeking to understand the causes of cancer with new genetic approaches in collaboration with the major research project "MUTOGRAPHS", was held on July 11 and 12, 2019 at the International Agency for Cancer Research.
The head of the Digestive Diseases Research Institute of Tehran University of Medical Sciences announced the fatty liver the most common liver disease in Iran, and warned against an increase in its prevalence due to the worrying trend of immobility and obesity in the country
Obesity is increasing more rapidly in the world’s rural areas than in cities, according to a new study of global trends in body-mass index (BMI).
Iranian researchers in "Iran in Transition", the article which was published in the April 2019 in International Journal of The Lancet, have broadly examined the health status in Iran over the past centuries up to now.